Research in my lab focuses on understanding the molecular mechanisms underlying metabolic diseases, particularly obesity, diabetes, and nonalcoholic fatty liver disease (NAFLD). We integrate genomic, transcriptomic, and epigenomic approaches to identify biomarkers and therapeutic targets. My team also investigates the role of mitochondrial function and dysfunction in these diseases, aiming to uncover novel interventions that can be translated into clinical practice. Our future research directions include leveraging precision medicine to tailor interventions for metabolic disorders and exploring the genetic basis of disease susceptibility in diverse populations.

More information on the Gerhard Laboratory is available at www.researchgate.net/profile/Glenn-Gerhard/12.